Stock News

AstraZeneca Flips Moderna Profits to Expand into Line of Rare-Disease Drugs

While AstraZeneca’s (AZN) COVID-19 vaccine still awaits approval for use in the U.S., the drugmaker is still cashing in on the progress of vaccines here in the states. Nicknamed the Oxford-vaccine, AstraZeneca’s vaccine, which has only gained approval in Europe, trails drugmakers Pfizer (PFE), BioNTech (BNTX) and Moderna (MRNA) in the U.S., yet still managed

Read More ›

USPS Commits to Buying Electric Vehicles, But Leaves Workhorse at the Altar

This week, Postmaster General Louis DeJoy told lawmakers the United States Postal Service plans to buy 10% electric vehicles as part of its multibillion-dollar plan to retire its 30-year-old fleet of delivery vehicles. After many had long expected the Postal Service to choose electric-vehicle maker Workhorse Group (WKHS) to fill out its new EV fleet,

Read More ›

Market Overview